Non-insulin oral drug(s)-Glucophage (Metformin) - Page 4 of 4 Posts on Medivizor
Navigation Menu

Non-insulin oral drug(s)-Glucophage (Metformin) Posts on Medivizor

Addition of insulin glargine to combination therapy with oral anti-diabetic drugs: a promising therapeutic option for type 2 diabetes

Addition of insulin glargine to combination therapy with oral anti-diabetic drugs: a promising therapeutic option for type 2 diabetes

Posted by on May 6, 2014 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of adding insulin glargine treatment  to metformin (Glucophage), glimepiride (Amaryl) or their combination in patients with uncontrolled type 2 diabetes mellitus. Some background Hyperglycemia (high blood glucose) in type 2 diabetes mellitus arises from a combination...

Read More

Is dapagliflozin add-on therapy beneficial?

Is dapagliflozin add-on therapy beneficial?

Posted by on Nov 5, 2013 in Diabetes mellitus | 0 comments

In a nutshell This trial evaluated the efficacy of dapagliflozin (Forxiga) in patients with type 2 diabetes mellitus (T2DM) uncontrolled with sitagliptin (Januvia), with or without metformin (Glucophage).  Some background T2DM is a condition in which the cells of the body are failing to use insulin properly (insulin resistance), resulting in...

Read More

AZD1656 reduces blood sugar levels in type 2 diabetes, but loses efficacy over time

AZD1656 reduces blood sugar levels in type 2 diabetes, but loses efficacy over time

Posted by on Aug 15, 2013 in Diabetes mellitus | 0 comments

In a nutshell In this study researchers examined the effect of a new drug, AZD1656, and its ability to control blood sugar levels in type 2 diabetic (T2D) patients. Some background Many different drugs, such as metformin (glucophage), are used to control blood sugar levels in T2D patients. However, not all patients manage to properly control their...

Read More

Evaluating safety and efficacy of a new drug for patients with type 2 diabetes mellitus

Evaluating safety and efficacy of a new drug for patients with type 2 diabetes mellitus

Posted by on Aug 15, 2013 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the efficacy and safety of adding gemigliptin versus sitagliptin to metformin treatment in patients with type 2 diabetes mellitus (T2DM). Some background T2DM is a condition in which patients have high blood glucose levels (hyperglycemia) when cells fail to respond to the normal actions of the hormone insulin or...

Read More

Comparing the effects of exenatide versus glimepiride in achieving glycaemic control in patients with type 2 diabetes mellitus poorly controlled with metformin

Posted by on Jun 2, 2013 in Diabetes mellitus | 0 comments

In a nutshell This study compared the efficacy and safety of exenatide versus glimepiride in achieving glycaemic (blood sugar) control in patients with type 2 diabetes mellitus (T2DM) uncontrolled by metformin.  Some background T2DM is a condition in which patients have high blood sugar levels (hyperglycemia). Metformin (Glucophage) is the...

Read More